Details of the Drug

General Information of Drug (ID: DM914KY)

• Drug Name: Human retinal pigment epithelial cell therapy

Indication

Disease Entry	ICD 11	Status	REF
Macular degeneration	9B78.3	Phase 1/2	[1]

• Cross-matching ID: TTD ID: D00WOX

References

• [1] Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet. 2015 Feb 7;385(9967):509-16.